12/19/2024
3:20 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/16/2024
6:00 AM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2024
6:00 AM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:13 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
5:14 PM | Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/10/2024
6:00 AM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
5:02 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
|
11/14/2024
10:50 AM | Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
11/14/2024
5:10 AM | Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
11/13/2024
4:58 PM | Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G/A | |
11/12/2024
6:06 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/31/2024
6:07 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/17/2024
9:34 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/16/2024
4:18 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
5:01 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/12/2024
6:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/28/2024
6:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/08/2024
8:25 AM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024
6:12 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/01/2024
3:31 PM | Avadel Pharmaceuticals (Issuer)
Glass Geoffrey Michael (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:32 PM | Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:35 PM | Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:36 PM | Avadel Pharmaceuticals (Issuer)
Ende Eric J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:37 PM | Avadel Pharmaceuticals (Issuer)
Thornton Peter J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
3:38 PM | Avadel Pharmaceuticals (Issuer)
Palczuk Linda (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2024
3:12 PM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/18/2024
6:25 AM | Avadel Pharmaceuticals (Filer)
| Form ARS | |
06/18/2024
6:17 AM | Avadel Pharmaceuticals (Filer)
| Form DEFA14A | |
06/18/2024
6:11 AM | Avadel Pharmaceuticals (Filer)
| Form DEF 14A | |
05/21/2024
4:27 PM | Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
05/21/2024
4:29 PM | Amin Naseem (Reporting)
Avadel Pharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/21/2024
6:04 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/08/2024
8:16 AM | Avadel Pharmaceuticals (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/08/2024
6:08 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
3:13 PM | Avadel Pharmaceuticals (Filer)
| Form 10-K/A | |
04/15/2024
6:00 AM | Avadel Pharmaceuticals (Filer)
| Form 8-A12B | |
04/15/2024
6:01 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:28 AM | Avadel Pharmaceuticals (Issuer)
Kim Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:35 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
5:24 AM | Avadel Pharmaceuticals (Issuer)
Divis Gregory J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
5:26 AM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
2025 AI Stock Picks: 2 Hidden Gems Under $10/Share (Ad) The AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget!
We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months. 👉[Click here to get your FREE report delivered instantly!] |
02/14/2024
6:11 AM | Avadel Pharmaceuticals (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G/A | |
02/13/2024
4:54 PM | Avadel Pharmaceuticals (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/13/2024
8:40 AM | Avadel Pharmaceuticals (Subject)
Polar Capital Holdings Plc (Filed by)
| Form SC 13G | |
02/12/2024
7:20 AM | Avadel Pharmaceuticals (Subject)
KOTLER KEVIN (Filed by)
| Form SC 13G/A | |
01/16/2024
3:36 PM | Avadel Pharmaceuticals (Issuer)
MCHUGH THOMAS S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/08/2024
6:20 AM | Avadel Pharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:15 PM | Avadel Pharmaceuticals (Issuer)
McCamish Mark Anthony (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/28/2023
1:54 PM | Avadel Pharmaceuticals (Subject)
McCamish Mark Anthony (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
Free AVDL Stock Alerts